11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
Every spring, Veristat attends and participates in the MassBio Annual Meeting and 2018 is no different. This year’s event will draw together more than 400 biopharma industry leaders and stakeholders to discuss timely and critical challenges facing the biopharma industry today, not only in Massachusetts, but around the world.
This year’s agenda highlights the following:
Fill out the form on the right hand side of this page to connect with Veristat at this meeting or anytime.
Please visit the MassBio website to get more details or register for this event.
11 min read
Jul 7, 2026 Veristat Blog
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
2 min read
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...